Torrent Pharmaceuticals (NSE:TORNTPHARM) Current Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
88 GF Score
Price ₹4,840.00
GF Value ₹4,655.27
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Torrent Pharmaceuticals's current ratio for the quarter that ended in Jun. 2026 was .

Torrent Pharmaceuticals has a current ratio of . It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Torrent Pharmaceuticals has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Torrent Pharmaceuticals's Current Ratio or its related term are showing as below:

NSE:TORNTPHARM' s Current Ratio Range Over the Past 10 Years
Min: 0.91   Med: 1.15   Max: 1.78
Current: 1.13

During the past 13 years, Torrent Pharmaceuticals's highest Current Ratio was 1.78. The lowest was 0.91. And the median was 1.15.

NSE:TORNTPHARM's Current Ratio is ranked worse than
77.98% of 999 companies
in the Drug Manufacturers industry
Industry Median: 1.92 vs NSE:TORNTPHARM: 1.13

Torrent Pharmaceuticals  (NSE:TORNTPHARM) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Torrent Pharmaceuticals Current Ratio Related Terms


Torrent Pharmaceuticals Current Ratio Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Current Ratio Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 0.98 1.03 1.19 1.13

Torrent Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.39 - 1.13 -

NSE:TORNTPHARM vs ZTS: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Current Ratio distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Current Ratio falls into.


NSE:TORNTPHARM
88GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Torrent Pharmaceuticals's Current Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Current Ratio (A: Mar. 2026 )=Total Current Assets (A: Mar. 2026 )/Total Current Liabilities (A: Mar. 2026 )
=93918.9/83433.3
=1.13

Torrent Pharmaceuticals's Current Ratio for the quarter that ended in Jun. 2026 is calculated as

Current Ratio (Q: Jun. 2026 )=Total Current Assets (Q: Jun. 2026 )/Total Current Liabilities (Q: Jun. 2026 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,840.00 is trading 4% above its estimated GF Value™ of ₹4,655.27. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:TORNTPHARM:

  • Current Ratio:
  • GF Value™: ₹4,655.27 vs. price of ₹4,840.00 (4% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
88GF Score

Get the complete analysis for NSE:TORNTPHARM

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,840.00
Price
₹4,655.27
GF Value